col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


40 Results       Page 1

 [1] 
Springer-Verlag: Cellular and Molecular Life Sciences
  original article Date Title Authors   All Authors
1 [GO] 2025―Jul―30 The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-β activation via blocking MAVS degradation Yuxin Zhang, Tong-Yun Wang, Huihui Yan, Zhoule Guo, Zhonghao Lian, Hailan Yao, et al. (+3)
2 [GO] 2025―Jun―23 THAP11-mediated K48- and K63-linked ubiquitination is essential for the degradation of porcine reproductive and respiratory syndrome virus nonstructural protein 1β Binghua Chen, Yongsheng Xie, Zhan He, Yongjie Chen, Jiecong Yan, Fangfang Li, et al. (+4)
3 [GO] 2025―May―21 Inflammatory metabolite 7α,25-OHC promotes TIMP1 expression in COVID-19 monocytes through synergy effect of SMARCC1/JUND/H3K27ac Ying Feng, Zheng Wu, Kefan Hu, Shenzhen Yuan, Jun Li, Yi Wang, et al. (+4)
4 [GO] 2025―Mar―13 Anti-interferon armamentarium of human coronaviruses Oyahida Khatun, Sumandeep Kaur, Shashank Tripathi
5 [GO] 2024―Dec―03 Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors Karthikeyan Subbarayan, Ahmed Al-Samadi, Helene Schäfer, Chiara Massa, Tuula Salo, Katharina Biehl, et al. (+8)
6 [GO] 2024―Dec―03 Heterogeneous neutrophils in lung transplantation and proteolytic CXCL8 activation in COVID-19, influenza and lung transplant patient lungs Seppe Cambier, Fabio Beretta, Amber Nooyens, Mieke Metzemaekers, Noëmie Pörtner, Janne Kaes, et al. (+12)
7 [GO] 2024―Oct―12 MERS-CoV-nsp5 expression in human epithelial BEAS 2b cells attenuates type I interferon production by inhibiting IRF3 nuclear translocation Y. Zhang, S. Kandwal, D. Fayne, N. J. Stevenson
8 [GO] 2024―Sep―16 Enhanced complement activation and MAC formation accelerates severe COVID-19 Calder R. Ellsworth, Zheng Chen, Mark T. Xiao, Chaosi Qian, Chenxiao Wang, Mst Shamima Khatun, et al. (+8)
9 [GO] 2024―Sep―07 Human coronaviruses activate and hijack the host transcription factor HSF1 to enhance viral replication Silvia Pauciullo, Anna Riccio, Silvia Santopolo, Anna Albecka, Guido Papa, Leo C. James, et al. (+4)
10 [GO] 2024―Aug―23 Innate immune signatures in the nasopharynx after SARS-CoV-2 infection and links with the clinical outcome of COVID-19 in Omicron-dominant period Hyunkyung Cha, Chan Mi Lee, Sujin Kim, Chang Kyung Kang, Pyoeng Gyun Choe, Yoon Kyung Jeon, et al. (+4)
11 [GO] 2024―Aug―15 SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses Thien-Phong Vu Manh, Carla Gouin, Julien De Wolf, Luc Jouneau, Florentina Pascale, Claudia Bevilacqua, et al. (+14)
12 [GO] 2024―Jul―27 SARS-CoV-2 E protein interacts with BRD2 and BRD4 SEED domains and alters transcription in a different way than BET inhibition Nieves Lara-Ureña, Elena Gómez-Marín, Isabel Pozuelo-Sánchez, José C. Reyes, Mario García-Domínguez
13 [GO] 2024―May―28 Disruption of pulmonary microvascular endothelial barrier by dysregulated claudin-8 and claudin-4: uncovered mechanisms in porcine reproductive and respiratory syndrome virus infection Weifeng Sun, Weixin Wu, Xinyu Fang, Xinna Ge, Yongning Zhang, Jun Han, et al. (+3)
14 [GO] 2024―Feb―18 Emerging role of complement in COVID-19 and other respiratory virus diseases Mark T. Xiao, Calder R. Ellsworth, Xuebin Qin
15 [GO] 2023―Nov―20 SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction Oyahida Khatun, Mansi Sharma, Rohan Narayan, Shashank Tripathi
16 [GO] 2023―Nov―09 The KxGxYR and DxE motifs in the C-tail of the Middle East respiratory syndrome coronavirus membrane protein are crucial for infectious virus assembly Lowiese Desmarets, Adeline Danneels, Julien Burlaud-Gaillard, Emmanuelle Blanchard, Jean Dubuisson, Sandrine Belouzard
17 [GO] 2023―Oct―05 Entropy driven cooperativity effect in multi-site drug optimization targeting SARS-CoV-2 papain-like protease Lili Duan, Bolin Tang, Song Luo, Danyang Xiong, Qihang Wang, Xiaole Xu, John Z. H. Zhang
18 [GO] 2023―Jul―28 Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients Seppe Cambier, Fabio Beretta, Noëmie Pörtner, Mieke Metzemaekers, Ana Carolina de Carvalho, Erik Martens, et al. (+13)
19 [GO] 2023―May―07 Neuronal progenitors of the dentate gyrus express the SARS-CoV-2 cell receptor during migration in the developing human hippocampus José Manuel Hernandez-Lopez, Cristina Hernandez-Medina, Cristina Medina-Corvalan, Mónica Rodenas, Almagro Francisca, Claudia Perez-Garcia, et al. (+4)
20 [GO] 2022―Dec―03 Neutrophils play a major role in the destruction of the olfactory epithelium during SARS-CoV-2 infection in hamsters Clara Bourgon, Audrey St Albin, Ophélie Ando-Grard, Bruno Da Costa, Roxane Domain, Brice Korkmaz, et al. (+3)
21 [GO] 2022―Nov―05 Induction of pulmonary HLA-G expression by SARS-CoV-2 infection Barbara Seliger, Simon Jasinski-Bergner, Chiara Massa, Anja Mueller, Katharina Biehl, Bo Yang, et al. (+6)
22 [GO] 2022―Jul―16 The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses Philippe Roingeard, Sébastien Eymieux, Julien Burlaud-Gaillard, Christophe Hourioux, Romuald Patient, Emmanuelle Blanchard
23 [GO] 2022―Jun―16 Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19 Aiwei Zhu, Fernando Real, Claude Capron, Arielle R. Rosenberg, Aymeric Silvin, Garett Dunsmore, et al. (+18)
24 [GO] 2022―Jun―13 Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels Erika Cecon, Daniela Fernandois, Nicolas Renault, Caio Fernando Ferreira Coelho, Jan Wenzel, Corentin Bedart, et al. (+8)
25 [GO] 2022―May―21 Role of LL-37 in thrombotic complications in patients with COVID-19 Zilei Duan, Juan Zhang, Xue Chen, Ming Liu, Hongwen Zhao, Lin Jin, et al. (+8)
26 [GO] 2022―May―19 Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming Sadiq Umar, Karol Palasiewicz, Anja Meyer, Prabhakaran Kumar, Bellur S. Prabhakar, Michael V. Volin, et al. (+6)
27 [GO] 2022―Apr―07 Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence Anna Riccio, Silvia Santopolo, Antonio Rossi, Sara Piacentini, Jean-Francois Rossignol, M. Gabriella Santoro
28 [GO] 2022―Mar―13 Hematopoietic responses to SARS-CoV-2 infection Shokrollah Elahi
29 [GO] 2022―Feb―20 Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, Qi Zhang, Lingzhi Fan, Yangxin Fang, et al. (+2)
30 [GO] 2022―Feb―20 Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection Russel J. Reiter, Ramaswamy Sharma, Fedor Simko, Alberto Dominguez-Rodriguez, Jan Tesarik, Richard L. Neel, et al. (+5)
31 [GO] 2022―Jan―17 Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells Davide Barbagallo, Concetta Ilenia Palermo, Cristina Barbagallo, Rosalia Battaglia, Angela Caponnetto, Vittoria Spina, et al. (+4)
32 [GO] 2022―Jan―10 The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses André Schreiber, Dorothee Viemann, Jennifer Schöning, Sebastian Schloer, Angeles Mecate Zambrano, Linda Brunotte, et al. (+9)
33 [GO] 2021―Nov―06 Carbon dioxide inhibits COVID-19-type proinflammatory responses through extracellular signal-regulated kinases 1 and 2, novel carbon dioxide sensors Hanna Galganska, Wieslawa Jarmuszkiewicz, Lukasz Galganski
34 [GO] 2021―Nov―03 Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants Deepali Gupta, Priyanka Sharma, Mandeep Singh, Mukesh Kumar, A. S. Ethayathulla, Punit Kaur
35 [GO] 2021―Oct―29 Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2 Andrei E. Siniavin, Maria A. Streltsova, Maria A. Nikiforova, Denis S. Kudryavtsev, Svetlana D. Grinkina, Vladimir A. Gushchin, et al. (+6)
36 [GO] 2021―Jul―05 Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs Sébastien Boutin, Dagmar Hildebrand, Steeve Boulant, Michael Kreuter, Jule Rüter, Srinivas Reddy Pallerla, et al. (+2)
37 [GO] 2021―Jan―15 Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release Sébastien Eymieux, Yves Rouillé, Olivier Terrier, Karin Seron, Emmanuelle Blanchard, Manuel Rosa-Calatrava, et al. (+3)
38 [GO] 2020―Aug―11 Advances in research on ACE2 as a receptor for 2019-nCoV Jie Wu, Wei Deng, Shumin Li, Xiuhong Yang
39 [GO] 2020―Jul―25 Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses Rajanish Giri, Taniya Bhardwaj, Meenakshi Shegane, Bhuvaneshwari R. Gehi, Prateek Kumar, Kundlik Gadhave, et al. (+2)
40 [GO] 2020―Jul―04 Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies Ivan Mercurio, Vincenzo Tragni, Francesco Busto, Anna De Grassi, Ciro Leonardo Pierri
 [1] 

40 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec